Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer
Clinical trial NCT06591650 · RECRUITING
Trial details
- NCT number
- NCT06591650
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-24
- Primary completion
- 2026-10-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.